Key result
The provided text is a bibliographic citation guide and does not contain any clinical trial data or findings.
Why the study?
Does the human rotavirus vaccine reduce rotavirus gastroenteritis-associated mortality and hospitalizations in resource-deprived areas in Africa?
Does the human rotavirus vaccine reduce rotavirus gastroenteritis-associated mortality and hospitalizations in resource-deprived areas in Africa?
Real-world data from Africa demonstrates that human rotavirus vaccine effectiveness is similar or superior to pre-licensure efficacy trials, supporting its use in resource-deprived settings.
No takes yet. Share an insight, caveat, or question.
RV vaccine impact in low-income countries warrants monitoring; leaves open optimization of schedules or formulations.
O’Ryan et al. (2015) studied this question. The provided text is a bibliographic citation guide and does not contain any clinical trial data or findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: